HIGHLIGHTS
- who: Pamela Soberanis Pina and collaborators from the AOPapardo, Italy Western Reserve University have published the Article: Case report: Osimertinib administration during pregnancy in a woman with advanced EGFR-mutant non-small cell lung cancer, in the Journal: (JOURNAL)
SUMMARY
The incidence of LC during pregnancy is unknown, with less than 100 reported cases, and information regarding recommended therapy in this setting is even more scarce. As genetic sequencing techniques are increasingly available, oncogenic driver mutations and other genomic alterations are frequently identified, guiding cancer therapy. Eight patients were diagnosed with LC during . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.